HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

When Economy Gets Tough, The Tough Stay Pretty, Retail Execs Tell CEW

This article was originally published in The Rose Sheet

  • News

Executive Summary

The beauty industry's performance is proving the "lipstick effect" right during a challenging economy, retail executives reported at April 14 Cosmetic Executive Women event on "The New Retail Reality.

You may also be interested in...



CVS Takes Its Prestige Offering Online With Beauty360.com

CVS/pharmacy is taking its prestige makeup and skin-care retail store online with Beauty360.com

CVS Takes Its Prestige Offering Online With Beauty360.com

CVS/pharmacy is taking its prestige makeup and skin-care retail store online with Beauty360.com

Olay Professional Pro-X Performs On Par With Top Rx Brand, At Half The Price?

Procter & Gamble is going after consumers who demand a bang for their buck with its wrinkle-targeting Olay Professional Pro-X line, which it claims offers Rx results at a much-reduced price

Table

View full table

Tags:
Latest Headlines

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales

See All
UsernamePublicRestriction

Register

RS016106

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By